Biocept Stock Five Year Return
Biocept fundamentals help investors to digest information that contributes to Biocept's financial success or failures. It also enables traders to predict the movement of Biocept Stock. The fundamental analysis module provides a way to measure Biocept's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biocept stock.
Biocept |
Biocept Company Five Year Return Analysis
Biocept's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
CompetitionAccording to the company disclosure, Biocept has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
All Next | Launch Module |
Biocept Fundamentals
Return On Equity | -1.87 | |||
Return On Asset | -0.52 | |||
Operating Margin | (10.38) % | |||
Current Valuation | 5.92 M | |||
Shares Outstanding | 2.63 M | |||
Shares Owned By Insiders | 9.20 % | |||
Shares Owned By Institutions | 1.98 % | |||
Number Of Shares Shorted | 29.73 K | |||
Price To Earning | 5.34 X | |||
Price To Book | 0.37 X | |||
Price To Sales | 0.20 X | |||
Revenue | 25.86 M | |||
Gross Profit | (2.58 M) | |||
EBITDA | (31.98 M) | |||
Net Income | (32.09 M) | |||
Cash And Equivalents | 27.57 M | |||
Cash Per Share | 1.63 X | |||
Total Debt | 12.11 M | |||
Debt To Equity | 0.33 % | |||
Current Ratio | 3.38 X | |||
Book Value Per Share | 0.12 X | |||
Cash Flow From Operations | (13.29 M) | |||
Short Ratio | 0.05 X | |||
Earnings Per Share | (48.17) X | |||
Price To Earnings To Growth | (0.04) X | |||
Target Price | 4.0 | |||
Number Of Employees | 50 | |||
Beta | 0.6 | |||
Market Capitalization | 1.14 M | |||
Total Asset | 30.87 M | |||
Retained Earnings | (298.44 M) | |||
Working Capital | 10.84 M | |||
Current Asset | 9.64 M | |||
Current Liabilities | 3.34 M | |||
Z Score | -15.64 | |||
Net Asset | 30.87 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.ZLAB | Zai Lab | |
ASLE | AerSale Corp | |
ATS | AT S Austria |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Biocept Stock
If you are still planning to invest in Biocept check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biocept's history and understand the potential risks before investing.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |